Article

Neurophenotypes of COVID-19: risk factors and recovery outcomes

2023-02-20

Abstract excerpt

<title>Abstract</title> <p>Coronavirus disease 2019 (COVID-19) infection is associated with risk of persistent neurocognitive and neuropsychiatric complications, termed “long COVID”. It is unclear whether the neuropsychological manifestations of COVID-19 present as a uniform syndrome or as distinct neurophenotypes with differing risk factors and recovery outcomes. We examined post-acute neuropsychological profile...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3e8aead2-720a-5bc5-92a3-3d35c90d0d8f
DOI: 10.21203/rs.3.rs-2363210/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Neurophenotypes of COVID-19: risk factors and recovery outcomesDOI 10.21203/rs.3.rs-2363210/v2Read

Neurocognitive Impairment After COVID-19: Mechanisms, Phenotypes, and Links to Alzheimer’s DiseaseSemantic proximity Read

The Cognitive and Psychiatric Subacute Impairment in severe Covid-19.Semantic proximity Read

[Post-COVID-19 condition-Clinical phenotyping in practice].Semantic proximity Read

The Impact of COVID-19 Infection on Cognitive Function and the Implication for Rehabilitation: a Systematic Review and Meta-AnalysisSemantic proximity Read

Dimensional structure of one-year post-COVID-19 neuropsychiatric and somatic sequelae and association with role impairmentSemantic proximity Read

Chronic post-COVID neuropsychiatric symptoms persisting beyond one year from infection: a case-control study and network analysisSemantic proximity Read

Neurologic and neuropsychiatric symptoms in long-COVID 19 syndrome: a systematic reviewSemantic proximity Read

Clinical Phenotyping of Long COVID Patients Evaluated in a Specialized Neuro-COVID Clinic.Semantic proximity Read

Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.Semantic proximity Read

Global Prevalence of Neurological Manifestations Among Patients Hospitalized with COVID-19: A Report of the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID) and the European Academy of Neurology [ENERGY] Registry CollaborativeSemantic proximity Read

Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAsSemantic proximity Read

Pre-Existing Neurological Conditions and COVID-19 Risk: A Commissioned Rapid ReviewSemantic proximity Read